This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
On the physician front, the core technology that is powering meetings between a physician and patient is also making engagement between a pharmarep and a physician possible. Similar to the spike in the use of telemedicine between patients and physicians, there has been a spike in virtual detailing between pharmareps and physicians.
This rose significantly to 332,881 by Q3 2021 as the pandemic continued. In Q4 2021 when some face-to-face interactions returned, the number reduced only to 289,511. They move from 10th position up to fourth in Q2 2021, a raise that is not confirmed by the IE which in fact shows that the company in blue has stayed outside the top five.
The days when a pharmarep can walk into any doctors' office at a specific time and expect to see the doctor if they were patient enough, could soon be a distant memory.
The findings presented here are based on pharma sales rep activities that were captured in Veeva CRM between 1 January 2020 and 5 April 2021. Before COVID-19, pharmaceutical sales reps had been accustomed to meeting HCPs in person. Emergence of digital. Will the HCP engagement model return to face to face?
Imagine what a pharmarep will look like in 10 years. Beginning June 2021, all new innovations for the Veeva CRM desktop experience will only be accessible through the Lightning user interface. Veeva CIO Forum, April 2021. Will they still be out driving all the time? Maybe they’ll just be using their phones.
As pharmareps’ access to physicians continues to decline, this case study examines the effectiveness of reaching physicians through other means—the EHR. This report compiled data from 10 studies, published from 2016 to 2021, to show that physicians spend an average of 4.5 Updated April 20, 2021. THE CHALLENGE.
According to Veeva Pulse data , COVID-19 has accelerated the shift to digital for life sciences, with significant growth in remote and digital engagement since early 2020, and a 10X increase of HCPs using three or more channels in their engagement with pharma 1.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content